TP53 and oesophageal cancer.
Mutations of the tumor suppressor gene TP53 have been detected in tumor tissues of a large variety of human malignancies and contribute to the development, progression and probably the prognosis of the disease. The pattern of somatic mutations in the TP53 gene in human tumors most often consists of a point mutation in one allele accompanied by loss or rearrangement of the second allele. Esophageal cancer is one of the most commonly mutated cancer, p53 mutations having an incidence greater than 80% in squamous cell carcinoma. The profile of distribution of these mutations in the TP53 gene is of interest to establish correlation between the exposure to carcinogens responsible for DNA mutations. The other form of esophageal cancer, Barrett's esophageal is a good model to study the role of TP53 in mammalian tumorigenesis.
Centre de Biogénétique, ETSBO, Brest, France.
C
C
Ferec
M A
MA
Giroux
M P
MP
Audrezet
M
M
Robaszkiewicz
D001471:Barrett Esophagus / Q000235:genetics; D002294:Carcinoma, Squamous Cell / Q000235:genetics; D018450:Disease Progression; D004938:Esophageal Neoplasms / Q000235:genetics*; D016158:Genes, p53; D006801:Humans; D009154:Mutation; D011379:Prognosis